Phoenix Biotech Acquisition Corp.
SEC CIK 1870404 · PBAX · last insider filing 2026-04-21
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Francois Eric | Director | filed 2026 - 2026 |
| Laporte Kathleen | Director | filed 2021 - 2026 |
| Atwood Brian G | Director · Chief Executive Officer | filed 2021 - 2026 |
| Ehrlich Christopher B | Director · Interim Chairman and CEO | filed 2021 - 2026 |
| Patel Shami | Director | filed 2024 - 2026 |
| Byrnes Michael | Director | filed 2024 - 2026 |
| Rolfe Lindsey | Director | filed 2024 - 2026 |
| Rapaport Robyn | Director | filed 2024 - 2024 |
| Corey Daniel | Director · Chief Technical Officer | filed 2024 - 2024 |
| Loewy Caroline M | Director | filed 2021 - 2024 |
| Kosacz Barbara | Director | filed 2021 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Kucharchuk Andrew Albert | Chief Financial Officer | filed 2024 - 2026 |
| Pierce Kristen | Chief Development Officer | filed 2024 - 2026 |
| Carter Charles Ross | Chief Financial Officer | filed 2024 - 2024 |
| Geffken Daniel E. | Chief Financial Officer | filed 2021 - 2024 |
| Fisher Douglas Carl | President | filed 2021 - 2024 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.